Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features.
Valentina GianniniS MazzettiI BertottoC ChiarenzaS CaudaE DelmastroC BraccoA Di DiaF LeoneE MedicoA PisacaneD RiberoM StasiD ReggePublished in: European journal of nuclear medicine and molecular imaging (2019)
If preliminary results of this study are confirmed, pretreatment PET and MRI could be useful to personalize patient treatment, e.g., avoiding toxicity of neoadjuvant therapy in patients predicted pR-.
Keyphrases
- rectal cancer
- locally advanced
- contrast enhanced
- pet ct
- positron emission tomography
- neoadjuvant chemotherapy
- computed tomography
- pet imaging
- magnetic resonance imaging
- phase ii study
- squamous cell carcinoma
- diffusion weighted imaging
- radiation therapy
- case report
- clinical trial
- bone marrow
- lymph node
- study protocol
- cell therapy
- open label
- double blind